Medicare by State. Covered Services Under Medicare Part B. Medicare Part B helps cover preventive services (like medical checkups and screenings) and medically necessary services (like supplies or services you need to treat a medical condition). See the table below for an overview of some of Medicare Part B benefits and services.
Febuxostat (INN; trade names Adenuric in Europe and New Zealand, Uloric in the US, Goturic in Latin America, Feburic in Japan) is a drug that inhibits xanthine oxidase, thus reducing production of uric acid in the body. It is used in the treatment of chronic gout and hyperuricemia. Febuxostat was discovered by scientists at the Japanese pharmaceutical company Teijin in 1998. Teijin partnered the drug with TAP Pharmaceuticals in the US and Ipsen in Europe.
Keeping your uric acid level low, less than 6 mg/dL, is the goal for long-term management of gout. Your gout may flare up when you start taking ULORIC. This may be due to crystals beginning to dissolve in your joints as your uric acid level goes down. If you have a flare while taking ULORIC, do not stop taking your medicine. Your healthcare professional may tell you to take other medicines to help prevent or manage flares during initial treatment. The most common side effects of ULORIC are liver problems, nausea, gout flares, joint pain, and rash.